106 related articles for article (PubMed ID: 32569864)
1. Lysine demethylase KDM3A regulates nanophotonic hyperthermia resistance generated by 2D silicene in breast cancer.
He C; Yu L; Ding L; Yao H; Chen Y; Hao Y
Biomaterials; 2020 Oct; 255():120181. PubMed ID: 32569864
[TBL] [Abstract][Full Text] [Related]
2. Engineering two-dimensional silicene composite nanosheets for dual-sensitized and photonic hyperthermia-augmented cancer radiotherapy.
Hu R; Chen Z; Dai C; Guo X; Feng W; Liu Z; Lin H; Chen Y; Wu R
Biomaterials; 2021 Feb; 269():120455. PubMed ID: 33162174
[TBL] [Abstract][Full Text] [Related]
3. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
Ramadoss S; Guo G; Wang CY
Oncogene; 2017 Jan; 36(1):47-59. PubMed ID: 27270439
[TBL] [Abstract][Full Text] [Related]
4. Two-Dimensional Silicene/Silicon Nanosheets: An Emerging Silicon-Composed Nanostructure in Biomedicine.
Ma L; Song X; Yu Y; Chen Y
Adv Mater; 2021 Aug; 33(31):e2008226. PubMed ID: 34050575
[TBL] [Abstract][Full Text] [Related]
5. Two-dimensional silicene composite nanosheets enable exogenous/endogenous-responsive and synergistic hyperthermia-augmented catalytic tumor theranostics.
Duan H; Guo H; Zhang R; Wang F; Liu Z; Ge M; Yu L; Lin H; Chen Y
Biomaterials; 2020 Oct; 256():120206. PubMed ID: 32599359
[TBL] [Abstract][Full Text] [Related]
6. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
Ramadoss S; Sen S; Ramachandran I; Roy S; Chaudhuri G; Farias-Eisner R
Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900
[TBL] [Abstract][Full Text] [Related]
7. Potentiated cytosolic drug delivery and photonic hyperthermia by 2D free-standing silicene nanosheets for tumor nanomedicine.
Wang F; Duan H; Zhang R; Guo H; Lin H; Chen Y
Nanoscale; 2020 Sep; 12(34):17931-17946. PubMed ID: 32845945
[TBL] [Abstract][Full Text] [Related]
8. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
9. The histone H3K9 demethylase KDM3A promotes anoikis by transcriptionally activating pro-apoptotic genes BNIP3 and BNIP3L.
Pedanou VE; Gobeil S; Tabariès S; Simone TM; Zhu LJ; Siegel PM; Green MR
Elife; 2016 Jul; 5():. PubMed ID: 27472901
[TBL] [Abstract][Full Text] [Related]
10. Construction of 2D Antimony(III) Selenide Nanosheets for Highly Efficient Photonic Cancer Theranostics.
Zhou Y; Feng W; Qian X; Yu L; Han X; Fan G; Chen Y; Zhu J
ACS Appl Mater Interfaces; 2019 Jun; 11(22):19712-19723. PubMed ID: 31066264
[TBL] [Abstract][Full Text] [Related]
11. [Knockdown of lysine-specific demethylase 3A (KDM3A) inhibits the invasion and migration of MDA-MB-231 breast cancer cells and arrests the cell cycle in the G0/G1 phase].
Gao W; Zhang T; Yao J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Sep; 37(9):808-814. PubMed ID: 34533128
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable and Excretable 2D W
Zhou B; Yin H; Dong C; Sun L; Feng W; Pu Y; Han X; Li X; Du D; Xu H; Chen Y
Adv Sci (Weinh); 2021 Dec; 8(24):e2101043. PubMed ID: 34716674
[TBL] [Abstract][Full Text] [Related]
13. Redox chemistry-enabled stepwise surface dual nanoparticle engineering of 2D MXenes for tumor-sensitive
Liu Z; Zhao M; Yu L; Peng W; Chen Y; Zhang S
Biomater Sci; 2022 Mar; 10(6):1562-1574. PubMed ID: 35175252
[TBL] [Abstract][Full Text] [Related]
14. Photonic cancer nanomedicine using the near infrared-II biowindow enabled by biocompatible titanium nitride nanoplatforms.
Wang C; Dai C; Hu Z; Li H; Yu L; Lin H; Bai J; Chen Y
Nanoscale Horiz; 2019 Mar; 4(2):415-425. PubMed ID: 32254094
[TBL] [Abstract][Full Text] [Related]
15. Optimization of the Preparation of Magnetic Liposomes for the Combined Use of Magnetic Hyperthermia and Photothermia in Dual Magneto-Photothermal Cancer Therapy.
T S A; Lu YJ; Chen JP
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707876
[TBL] [Abstract][Full Text] [Related]
16. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
[TBL] [Abstract][Full Text] [Related]
17. The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer.
Wade MA; Jones D; Wilson L; Stockley J; Coffey K; Robson CN; Gaughan L
Nucleic Acids Res; 2015 Jan; 43(1):196-207. PubMed ID: 25488809
[TBL] [Abstract][Full Text] [Related]
18. An injectable thermosensitive photothermal-network hydrogel for near-infrared-triggered drug delivery and synergistic photothermal-chemotherapy.
Liu C; Guo X; Ruan C; Hu H; Jiang BP; Liang H; Shen XC
Acta Biomater; 2019 Sep; 96():281-294. PubMed ID: 31319202
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles-encapsulated let-7i shed from bone mesenchymal stem cells suppress lung cancer via KDM3A/DCLK1/FXYD3 axis.
Liu J; Feng Y; Zeng X; He M; Gong Y; Liu Y
J Cell Mol Med; 2021 Feb; 25(4):1911-1926. PubMed ID: 33350586
[TBL] [Abstract][Full Text] [Related]
20. Lysine demethylase 3a in craniofacial and neural development during Xenopus embryogenesis.
Lee HK; Ismail T; Kim C; Kim Y; Park JW; Kwon OS; Kang BS; Lee DS; Kwon T; Park TJ; Lee HS
Int J Mol Med; 2019 Feb; 43(2):1105-1113. PubMed ID: 30569092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
